Literature DB >> 25386457

Can Metabotropic Glutamate Receptor 7 (mGluR 7) be a Novel Target for Analgesia?

Shivaprakash G1, Punya Suvarna2, Sanjay Hadigal3, Priyanka Kamath3, Natesh Prabhu3, Ashok Shenoy K4, Pallavi Lc5.   

Abstract

INTRODUCTION: The present study was carried out to study the role of metabotropic glutamate receptor 7 (mGluR7) using its agonist, N,N'-bis(diphenylmethyl)-1,-ethanediamine (AMN082) for nociceptive stimuli, in animal models. By conducting this research, we aim to introduce a novel target for acute pain management.
OBJECTIVE: To study the role of metabotropic glutamate receptor 7 (mGluR7), in analgesia, using mGluR7 agonist AMN082 in animal models.
MATERIALS AND METHODS: Swiss albino mice of either sex, weighing 20-30gm were used for the study. The animals were divided into 3 groups with 6 mice in each group: Control or Normal group received 0.5% methylcellulose in normal saline; Standard group received the drug tramadol HCl at 40mg/kg; and test group received drug AMN 082 at 5mg/kg. All the drugs were administered by intraperitoneal route. Hot plate test and Tail flick test were done to evaluate the analgesic effect of the drug. Reaction time for the end points in both the models were noted before drug administration at 0 min and after drug administration at 15, 30,60,90 and 120 min. Statistical analysis was done using One-Way-ANOVA followed by Tukeys post hoc test. p-value was considered significant at ≤ 0.05.
RESULTS: The group that received AMN082 showed significantly lesser reaction time compared to normal and standard groups in both the analgesia models.
CONCLUSION: The mGluR 7 stimulation by an agonist AMN082, did not show analgesic effect but induced hyperalgesia in response to thermal nociceptive stimuli.

Entities:  

Keywords:  Analgesia; Hot plate test; Metabotropic; Tail flick test

Year:  2014        PMID: 25386457      PMCID: PMC4225909          DOI: 10.7860/JCDR/2014/10377.4884

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling.

Authors:  Stefania Risso Bradley; Jason M Uslaner; Rose B Flick; Ariel Lee; Kristina M Groover; Peter H Hutson
Journal:  Pharmacol Biochem Behav       Date:  2011-11-25       Impact factor: 3.533

2.  mGluR7's lucky number.

Authors:  P Jeffrey Conn; Colleen M Niswender
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

3.  Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors.

Authors:  Enza Palazzo; Yu Fu; Guangchen Ji; Sabatino Maione; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2008-05-16       Impact factor: 5.250

4.  Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission.

Authors:  Katarzyna Stachowicz; Piotr Brañski; Kinga Kłak; Herman van der Putten; John F Cryan; Peter J Flor; Pilc Andrzej
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

5.  Target-cell-specific concentration of a metabotropic glutamate receptor in the presynaptic active zone.

Authors:  R Shigemoto; A Kulik; J D Roberts; H Ohishi; Z Nusser; T Kaneko; P Somogyi
Journal:  Nature       Date:  1996-06-06       Impact factor: 49.962

6.  The metabotropic glutamate receptor mGlu7 activates phospholipase C, translocates munc-13-1 protein, and potentiates glutamate release at cerebrocortical nerve terminals.

Authors:  Ricardo Martín; Thierry Durroux; Francisco Ciruela; Magdalena Torres; Jean-Philippe Pin; José Sánchez-Prieto
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

7.  Presynaptic glutamate receptors depress excitatory monosynaptic transmission between mouse hippocampal neurones.

Authors:  I D Forsythe; J D Clements
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

Review 8.  Metabotropic glutamate receptors as targets for analgesia: antagonism, activation, and allosteric modulation.

Authors:  Michael C Montana; Robert W Gereau
Journal:  Curr Pharm Biotechnol       Date:  2011-10       Impact factor: 2.837

9.  Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain.

Authors:  Maria Osikowicz; Joanna Mika; Wioletta Makuch; Barbara Przewlocka
Journal:  Pain       Date:  2008-04-28       Impact factor: 6.961

10.  Periaqueductal gray metabotropic glutamate receptor subtype 7 and 8 mediate opposite effects on amino acid release, rostral ventromedial medulla cell activities, and thermal nociception.

Authors:  Ida Marabese; Francesca Rossi; Enza Palazzo; Vito de Novellis; Katarzyna Starowicz; Luigia Cristino; Daniela Vita; Luisa Gatta; Francesca Guida; Vincenzo Di Marzo; Francesco Rossi; Sabatino Maione
Journal:  J Neurophysiol       Date:  2007-05-16       Impact factor: 2.714

View more
  4 in total

Review 1.  Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications.

Authors:  Enza Palazzo; Ida Marabese; Vito de Novellis; Francesco Rossi; Sabatino Maione
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 2.  The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum.

Authors:  Serena Boccella; Ida Marabese; Francesca Guida; Livio Luongo; Sabatino Maione; Enza Palazzo
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 3.  Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors.

Authors:  Mariacristina Mazzitelli; Peyton Presto; Nico Antenucci; Shakira Meltan; Volker Neugebauer
Journal:  Cells       Date:  2022-08-21       Impact factor: 7.666

4.  Negative allosteric modulation of the mGlu7 receptor reduces visceral hypersensitivity in a stress-sensitive rat strain.

Authors:  Rachel D Moloney; Anna V Golubeva; Richard M O'Connor; Mikhail Kalinichev; Timothy G Dinan; John F Cryan
Journal:  Neurobiol Stress       Date:  2015-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.